Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT) [clinicaltrials_resource:NCT00505284/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT) [clinicaltrials_resource:NCT00505284/outcome/1]
Bio2RDF identifier
NCT00505284/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00505284/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
ITT Population
ITT Population. A responder wa ...... from Baseline to Week 15/EOT.
ITT Population. A responder wa ...... from Baseline to Week 15/EOT.
Intent-to-Treat (ITT) Populati ...... ficacy assessment at Baseline.
Subset of ITT population used, ...... from Early Termination visit.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and Week 15
Baseline and Week 15/EOT
Baseline to Week 15
Baseline to Week 15/EOT
Baseline, Week 1 to Week 17
Week 15/EOT
type [clinicaltrials_vocabulary:type]
alternate
Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT)
@en
identifier
clinicaltrials_resource:NCT00505284/outcome/1
title
Average of last 7 available sc ...... vation carried forward (BOCF).
@en
type
label
Change in Average Pain Scores ...... esource:NCT00505284/outcome/1]
@en